Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11969175 | 0.88 | CALML3 (0.50) | GRM2F10 | |
| SCHEMBL11968768 | 0.87 | F10 (0.41) | GRM2F10 | |
| SCHEMBL11969542 | 0.85 | MAOA (0.54) | F10 | |
| SCHEMBL13428316 | 0.85 | F10 (0.41) | GRM2F10 | |
| SCHEMBL11968859 | 0.83 | MAOA (0.56) | F10 | |
| SCHEMBL11969009 | 0.81 | F10 (0.45) | F10 | |
| SCHEMBL11969072 | 0.80 | MAOA (0.58) | — | |
| SCHEMBL11969777 | 0.79 | MAOA (0.52) | F10 | |
| SCHEMBL13428748 | 0.79 | MAOA (0.52) | F10 | |
| SCHEMBL15828770 | 0.78 | CALML3 (0.53) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8242113-B2 | Oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone pharmaceutical compositions thereof | LEGOCHEM BIOSCIENCES, INC. (KR) | 2012-08-14 | — | — | US | disclosed |
| US-20110178293-A1 | Novel Oxazolidinone Derivatives with Cyclic Amidoxime or Cyclic Amidrazone and Pharmaceutical Compositions Thereof | LEGOCHEM BIOSCIENCE LTD. (KR) | 2011-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178293-A1 | Novel Oxazolidinone Derivatives with Cyclic Amidoxime or Cyclic Amidrazone and Pharmaceutical Compositions Thereof | PAM, PYCARD, PEPD | GRM2 4072/4885F10 3087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.